Garcinol and Anacardic Acid, Natural Inhibitors of Histone Acetyltransferases, Inhibit Rhabdomyosarcoma Growth and Proliferation
暂无分享,去创建一个
M. Tarnowski | D. Rogińska | B. Machaliński | M. Perużyńska | Patrycja Tomasiak | Joanna Janisiak | Magdalena Perużyńska
[1] M. Shariati,et al. Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates , 2021, Nutrients.
[2] M. Tarnowski,et al. Protein Arginine Methyltransferase (PRMT) Inhibitors—AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures , 2021, International journal of molecular sciences.
[3] M. Tarnowski,et al. Garcinol—A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug , 2021, International journal of molecular sciences.
[4] L. Doyle,et al. Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours , 2021, Histopathology.
[5] J. Ro,et al. The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities , 2020, Advances in anatomic pathology.
[6] M. T. Islam,et al. Anti-Inflammatory, Antinociceptive, and Antioxidant Properties of Anacardic Acid in Experimental Models , 2020, ACS Omega.
[7] K. Ahn,et al. Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells , 2020, Biomedicines.
[8] Guoxiong Xu,et al. Garcinol Alone and in Combination With Cisplatin Affect Cellular Behavior and PI3K/AKT Protein Phosphorylation in Human Ovarian Cancer Cells , 2020, Dose-response : a publication of International Hormesis Society.
[9] Anton G. Henssen,et al. Current and Future Treatment Strategies for Rhabdomyosarcoma , 2019, Front. Oncol..
[10] M. Rots,et al. The timeline of epigenetic drug discovery: from reality to dreams , 2019, Clinical Epigenetics.
[11] Qiu Sun,et al. Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism. , 2019, European journal of medicinal chemistry.
[12] R. Schobert,et al. Chemical and Biological Aspects of Garcinol and Isogarcinol: Recent Developments , 2019, Chemistry & biodiversity.
[13] Chen Li,et al. Garcinol exerts anti-cancer effect in human cervical cancer cells through upregulation of T-cadherin. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[14] R. Liang,et al. Anticancer effects of plant derived Anacardic acid on human breast cancer MDA-MB-231 cells. , 2018, American journal of translational research.
[15] D. Neal,et al. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway , 2018, BMC Complementary and Alternative Medicine.
[16] Z. Long,et al. Anacardic acid induces cell apoptosis of prostatic cancer through autophagy by ER stress/DAPK3/Akt signaling pathway , 2017, Oncology reports.
[17] M. Saidijam,et al. Garcinol exhibits anti-proliferative activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells , 2017, Human & experimental toxicology.
[18] J. McGowan-Jordan,et al. Update on molecular findings in rhabdomyosarcoma. , 2017, Pathology.
[19] Baheyeldin Salem,et al. Childhood Rhabdomyosarcoma in Association With a RASopathy Clinical Phenotype and Mosaic Germline SOS1 Duplication , 2016, Journal of pediatric hematology/oncology.
[20] Satya N. Das,et al. Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer , 2016, Tumor Biology.
[21] Yuxin Tang,et al. Anacardic acid sensitizes prostate cancer cells to radiation therapy by regulating H2AX expression. , 2015, International journal of clinical and experimental pathology.
[22] M. Tsai,et al. Antitumor Activity of Garcinol in Human Prostate Cancer Cells and Xenograft Mice. , 2015, Journal of agricultural and food chemistry.
[23] M. Hatley,et al. Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems , 2015, Nature Reviews Cancer.
[24] Dongni Zhou,et al. Head and neck rhabdomyosarcoma: follow-up results of four cases and review of the literature. , 2015, International journal of clinical and experimental pathology.
[25] M. Ratajczak,et al. 5‑Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin‑like growth factor 2 expression and reactivating the H19 gene product miR‑675, which negatively affects insulin‑like growth factors and insulin signaling. , 2015, International journal of oncology.
[26] M. Cieśla,et al. MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development. , 2014, The international journal of biochemistry & cell biology.
[27] Wen-feng Gou,et al. Anacardic Acid Enhances the Proliferation of Human Ovarian Cancer Cells , 2014, PloS one.
[28] T. Kundu,et al. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells , 2013, BMC Cancer.
[29] B. Bao,et al. Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling. , 2012, Carcinogenesis.
[30] S. Sleijfer,et al. The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study. , 2012, Anticancer research.
[31] B. Bao,et al. Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells , 2012, Molecular Cancer Therapeutics.
[32] K. Girish,et al. Emerging roles of anacardic acid and its derivatives: a pharmacological overview. , 2012, Basic & clinical pharmacology & toxicology.
[33] Zhiwei Wang,et al. Apoptosis‐inducing effect of garcinol is mediated by NF‐κB signaling in breast cancer cells , 2010, Journal of cellular biochemistry.
[34] C. Klinge,et al. Anacardic Acid Inhibits Estrogen Receptor α–DNA Binding and Reduces Target Gene Transcription and Breast Cancer Cell Proliferation , 2010, Molecular Cancer Therapeutics.
[35] Chi-Tang Ho,et al. Effects of garcinol and its derivatives on intestinal cell growth: Inhibitory effects and autoxidation-dependent growth-stimulatory effects. , 2007, Free radical biology & medicine.
[36] D. Parham,et al. Rhabdomyosarcomas in adults and children: an update. , 2006, Archives of pathology & laboratory medicine.
[37] Takayoshi Suzuki,et al. Epigenetic control using natural products and synthetic molecules. , 2006, Current medicinal chemistry.
[38] W. Reik,et al. Epigenetic Reprogramming in Mammalian Development , 2001, Science.
[39] Jen-kun Lin,et al. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. , 2001, Journal of agricultural and food chemistry.
[40] G. Merlino,et al. Rhabdomyosarcoma – working out the pathways , 1999, Oncogene.
[41] A. Stout. RHABDOMYOSARCOMA OF THE SKELETAL MUSCLES , 1946, Annals of surgery.
[42] M. Tarnowski,et al. Trichostatin A Inhibits Rhabdomyosarcoma Proliferation and Induces Differentiation through MyomiR Reactivation. , 2019, Folia biologica.
[43] J. Khan,et al. Pediatric Rhabdomyosarcoma. , 2015, Critical reviews in oncogenesis.
[44] L. Yamasaki. Role of the RB tumor suppressor in cancer. , 2003, Cancer treatment and research.